Fonar (FONR) Competitors $16.09 +0.09 (+0.56%) Closing price 04:00 PM EasternExtended Trading$16.08 -0.01 (-0.06%) As of 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock FONR vs. TMCI, OM, CLPT, RXST, NPCE, SNWV, NNOX, CATX, DRTS, and NYXHShould you be buying Fonar stock or one of its competitors? The main competitors of Fonar include Treace Medical Concepts (TMCI), Outset Medical (OM), ClearPoint Neuro (CLPT), RxSight (RXST), NeuroPace (NPCE), Sanuwave Health (SNWV), Nano-X Imaging (NNOX), Perspective Therapeutics (CATX), Alpha Tau Medical (DRTS), and Nyxoah (NYXH). These companies are all part of the "medical equipment" industry. Fonar vs. Its Competitors Treace Medical Concepts Outset Medical ClearPoint Neuro RxSight NeuroPace Sanuwave Health Nano-X Imaging Perspective Therapeutics Alpha Tau Medical Nyxoah Fonar (NASDAQ:FONR) and Treace Medical Concepts (NASDAQ:TMCI) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, media sentiment, valuation, risk, dividends, analyst recommendations, institutional ownership and earnings. Do analysts rate FONR or TMCI? Treace Medical Concepts has a consensus target price of $10.52, suggesting a potential upside of 79.77%. Given Treace Medical Concepts' stronger consensus rating and higher probable upside, analysts plainly believe Treace Medical Concepts is more favorable than Fonar.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Fonar 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Treace Medical Concepts 0 Sell rating(s) 4 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.33 Does the media prefer FONR or TMCI? In the previous week, Fonar had 2 more articles in the media than Treace Medical Concepts. MarketBeat recorded 5 mentions for Fonar and 3 mentions for Treace Medical Concepts. Treace Medical Concepts' average media sentiment score of 0.93 beat Fonar's score of 0.35 indicating that Treace Medical Concepts is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Fonar 0 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Treace Medical Concepts 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has higher earnings and valuation, FONR or TMCI? Fonar has higher earnings, but lower revenue than Treace Medical Concepts. Treace Medical Concepts is trading at a lower price-to-earnings ratio than Fonar, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioFonar$102.88M0.97$10.57M$1.2512.87Treace Medical Concepts$209.36M1.76-$55.74M-$0.85-6.88 Is FONR or TMCI more profitable? Fonar has a net margin of 8.19% compared to Treace Medical Concepts' net margin of -25.14%. Fonar's return on equity of 5.31% beat Treace Medical Concepts' return on equity.Company Net Margins Return on Equity Return on Assets Fonar8.19% 5.31% 3.97% Treace Medical Concepts -25.14%-48.69%-24.59% Which has more risk & volatility, FONR or TMCI? Fonar has a beta of 1, suggesting that its stock price has a similar volatility profile to the S&P 500.Comparatively, Treace Medical Concepts has a beta of 0.69, suggesting that its stock price is 31% less volatile than the S&P 500. Do insiders & institutionals hold more shares of FONR or TMCI? 50.6% of Fonar shares are held by institutional investors. Comparatively, 84.1% of Treace Medical Concepts shares are held by institutional investors. 1.6% of Fonar shares are held by company insiders. Comparatively, 27.7% of Treace Medical Concepts shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth. SummaryFonar and Treace Medical Concepts tied by winning 8 of the 16 factors compared between the two stocks. Get Fonar News Delivered to You Automatically Sign up to receive the latest news and ratings for FONR and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding FONR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart FONR vs. The Competition Export to ExcelMetricFonarMED PRODUCTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$99.76M$10.23B$5.57B$9.31BDividend YieldN/A2.09%4.23%4.03%P/E Ratio12.8716.9628.6119.73Price / Sales0.9729.09411.30174.40Price / Cash5.3022.6736.0257.96Price / Book0.653.598.235.67Net Income$10.57M$233.40M$3.23B$257.79M7 Day Performance4.08%-2.70%0.01%0.54%1 Month Performance13.23%1.84%5.63%8.86%1 Year Performance-7.42%-18.53%26.55%14.22% Fonar Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)FONRFonar1.227 of 5 stars$16.09+0.6%N/A-4.8%$99.76M$102.88M12.87480High Trading VolumeTMCITreace Medical Concepts2.509 of 5 stars$5.99-0.2%$10.52+75.6%-30.0%$376.71M$210.82M-7.05250News CoveragePositive NewsOMOutset Medical1.7268 of 5 stars$18.81-3.0%$29.50+56.8%-71.4%$333.31M$113.69M-0.65520News CoverageAnalyst ForecastGap DownCLPTClearPoint Neuro1.8249 of 5 stars$11.85+3.9%$25.00+111.0%+48.3%$331.68M$31.39M-15.59110RXSTRxSight2.2272 of 5 stars$7.74-3.3%$18.44+138.3%-84.7%$314.53M$148.31M-11.55220Analyst DowngradeHigh Trading VolumeNPCENeuroPace3.543 of 5 stars$9.55+0.3%$17.00+78.0%+21.4%$313.23M$84.31M-11.37170Positive NewsSNWVSanuwave HealthN/A$36.16+4.0%N/AN/A$309.39M$36.19M-7.9440NNOXNano-X Imaging2.5752 of 5 stars$5.15+1.8%$9.50+84.5%-44.7%$297.57M$11.28M-5.72190News CoveragePositive NewsAnalyst UpgradeCATXPerspective Therapeutics2.3652 of 5 stars$4.00+0.5%$12.56+213.9%-68.4%$296.91MN/A0.0070News CoverageDRTSAlpha Tau Medical3.1265 of 5 stars$3.23+5.6%$8.00+147.7%+48.6%$273.97MN/A-7.0280Gap UpHigh Trading VolumeNYXHNyxoah2.8504 of 5 stars$7.84+3.7%$14.50+84.9%-14.7%$267.03M$4.36M-3.68110Positive News Related Companies and Tools Related Companies Treace Medical Concepts Competitors Outset Medical Competitors ClearPoint Neuro Competitors RxSight Competitors NeuroPace Competitors Sanuwave Health Competitors Nano-X Imaging Competitors Perspective Therapeutics Competitors Alpha Tau Medical Competitors Nyxoah Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:FONR) was last updated on 7/16/2025 by MarketBeat.com Staff From Our PartnersRevolutionary AI Tech Targets Early Diabetic Blindness Detection FDA Trial UnderwayTiny Stock, Massive Potential— this company’s AI platform is a game changer for healthcare!Interactive Offers | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored[ATTENTION] This Crypto Rocket Is About Launch…Every crypto bull market ends with a final surge — the window where fortunes are made fast. According to tw...Crypto Swap Profits | SponsoredBank of America Says Gold Could Hit $4,000. Here How to Get Paid“I’ve always hated gold. It doesn’t pay dividends… it just sits there.” That’s what one income strategist b...Investors Alley | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Fonar Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Fonar With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free FONR Stock Alerts